Welcome to our dedicated page for Slide Insurance Holdings SEC filings (Ticker: SLDE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Slide Insurance Holdings, Inc. (SLDE) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a Nasdaq Global Select Market issuer with common stock registered under Section 12(b) of the Exchange Act, Slide submits current and periodic reports that describe its financial condition, results of operations, and significant corporate events.
Investors can review Slide’s Form 8-K filings for material developments such as quarterly earnings announcements, executive leadership changes, and key employment agreements. For example, the company has used Form 8-K to furnish press releases announcing results for quarters ended June 30 and September 30, and to disclose the departure and appointment of a Chief Financial Officer, along with the terms of an employment agreement and related compensation structure.
Through its SEC reports, Slide also documents matters like stock exchange listing details, index inclusion, and governance updates. These filings complement the company’s earnings releases by providing formal descriptions of events, executive roles, and compensation arrangements, as well as the legal framework around change-of-control and severance provisions.
On Stock Titan, users can access these filings as they are made available on EDGAR and use AI-powered summaries to interpret lengthy documents such as 8-Ks and, when filed, 10-K and 10-Q reports. The platform also highlights items related to executive compensation and leadership transitions, helping readers quickly understand the implications of each filing. This page is a resource for anyone analyzing SLDE’s regulatory history, financial reporting, and corporate governance disclosures.
Slide Insurance Holdings Chief Risk Officer Matthew Paul Larson exercised stock options and sold the resulting shares on the same day. He exercised options to acquire 11,250 shares of common stock at $0.79 per share, then sold 11,250 shares at $18.00 per share in an open-market transaction. The activity was carried out under a Rule 10b5-1 trading plan adopted on December 4, 2025. Following the transactions, he continued to hold 53,750 stock options and no shares from this exercised lot.
Slide Insurance Holdings, Inc. announced that its board has authorized a new common stock repurchase program of up to $125 million of its shares. The authorization is effective immediately, has no expiration date, and may be modified, suspended or discontinued at any time.
The company also reported it has completed its initial $120 million repurchase program, under which it bought 7,109,417 shares at a weighted average price of $16.88. Future repurchases may occur through open-market purchases, privately negotiated transactions or Rule 10b5-1 plans, with timing and amounts driven by market conditions and the company’s capital needs.
Slide Insurance Holdings director Robert Gries Jr., through GRM Family Limited Partnership, reported open-market sales of a total of 56,424 shares of SLDE common stock over two days. The partnership sold 28,212 shares on March 17 at an average of $18.35 per share and 28,212 shares on March 18 at an average of $17.85 per share. These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 12, 2025. After the sales, indirect holdings through the partnership were 1,974,841 shares, and a separate line shows 843,804 shares held directly, indicating he retains a substantial position in the company.
Slide Insurance Holdings, Inc. director and President & COO Lucas Shannon reported that entity Securus Risk Management LLC, which he controls, sold 32,263 shares of common stock in open-market transactions on March 16–17, 2026 at prices around $18.13–$18.44 per share under a pre-arranged Rule 10b5-1 trading plan. After these sales, Securus Risk Management LLC held 1,553,108 shares indirectly. Separate footnotes disclose that Shannon’s spouse, through various entities and trusts, also beneficially owns and sold additional shares pursuant to a 10b5-1 plan, with Shannon disclaiming beneficial ownership beyond any pecuniary interest.
Slide Insurance Holdings, Inc. director and CEO Bruce Lucas reported open-market sales of 326,216 shares of common stock by IIM Holdings II, LLC on March 16–17, 2026, at prices around $18.13–$18.44 per share. These trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025. After the sales, IIM Holdings II, LLC still held 38,895,317 shares of Slide Insurance common stock. The filing also shows Lucas holding 1,123,646 shares directly, additional indirect holdings through his spouse, and shares held in two irrevocable trusts for which he serves as trustee, with standard disclaimers that he only beneficially owns the extent of his pecuniary interest.
SLDE sale notice: GRM Family Limited Partnership reported a sale of 28,212 shares of Common Stock on 03/17/2026 for $517,673.27 via a Form 144 filing. The filing identifies the shares and the dollar amount of the proposed resale; cash accrues to the selling holder.
Slide Insurance Holdings director Stephen L. Rohde reported an exercise-and-sale transaction involving 10,000 shares of Common Stock. On March 13, 2026, he exercised stock options to acquire 10,000 shares of Common Stock at an exercise price of $0.0018 per share. The stock options were fully vested and exercisable. That same day, he sold 10,000 shares of Common Stock in the open market at a price of $17.78 per share, resulting in no directly held Common Stock after the sale. Following the option exercise, he continued to hold 7,500 stock options directly.
Slide Insurance Holdings Chief Risk Officer Matthew Paul Larson exercised stock options for 11,250 shares of common stock at an exercise price of $0.79 per share and immediately sold the same 11,250 shares at $18.00 per share. The transactions were carried out on March 16, 2026 pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on December 4, 2025. After these transactions, he reported no directly held common shares, while his reported stock option position in this grant stood at 65,000 options following the exercise.
SLDE reports proposed and recent transactions by Stephen Rohde and a planned option exercise. The filing lists a 03/13/2026 planned stock option exercise for 10,000 Common shares (cash exercise). It also records recent sales by Stephen Rohde: 9,335 shares on 02/27/2026 for $175,778.05, 5,000 shares on 03/03/2026 for $95,800.00, and 5,000 shares on 03/04/2026 for $97,500.00.